ICOSLG Antikörper

Produktnummer ABIN400712

Produktdetails anti-ICOSLG Antikörper

Target: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser ICOSLG Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Spezifität: This antibody reacts to Inducible T-cell Co-stimulator Ligand (CD275/ICOS Ligand).

Kreuzreaktivität (Details): Species reactivity (tested):Human.

Produktmerkmale: Synonyms: B7 homolog 2, B7-like protein Gl50, B7-related protein 1, ICOSLG, B7H2, B7RP1, B7RP-1,ICOSL, KIAA0653

Aufreinigung: Affinity Chromatography.

Immunogen: Recombinant protein Human B7H2-mIg fusion protein.

Klon: 2D3

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: ELISA. Flow Cytometry. Immunoprecipitation. Immunohistochemistry on Paraffin Sections: 1/50. This CD275/ICOS Ligand antibody was validated for use in immunohistochemistry on apanel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat inducedantigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slideswere incubated with biotinylated secondary antibody LS-D2, followed by alkalinephosphatase-streptavidin and chromogen.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu ICOSLG

Target: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Andere Bezeichnung: CD275 / ICOS Ligand (ICOSLG Produkte)

Synonyme: ICOSLG antikoerper, AU044799 antikoerper, B7-H2 antikoerper, B7RP-1 antikoerper, B7h antikoerper, BG071784 antikoerper, GI50 antikoerper, GL50 antikoerper, GL50-B antikoerper, ICOS-L antikoerper, Icoslg antikoerper, LICOS antikoerper, Ly115l antikoerper, mKIAA0653 antikoerper, B7H2 antikoerper, B7RP1 antikoerper, CD275 antikoerper, ICOSL antikoerper, Icosl antikoerper, RGD1562791 antikoerper, inducible T-cell costimulator ligand antikoerper, icos ligand antikoerper, inducible T-cell co-stimulator ligand antikoerper, ICOSLG antikoerper, Icosl antikoerper, Icoslg antikoerper

Hintergrund: ICOS ligand (inducible T cell co stimulator ligand) is a member of the B7 family and the immunoglobulin superfamily. Human ICOS ligand is expressed by activated monocytes/macrophages and dendritic cells. It binds to a CD28 like receptor, inducible costimulator molecule (ICOS, AILIM, CRP-1), which is expressed by activated T cells. This interaction plays an important role in the T cell costimulation pathway.Synonyms: B7 homolog 2, B7-like protein Gl50, B7-related protein 1, B7H2, B7RP-1, B7RP1, ICOSL, ICOSLG, KIAA0653

Gen-ID: 23308

UniProt: O75144

Pathways: Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation